Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Certificate of Amendment to the Amended and Restated Articles of Incorporation of CNS Pharmaceuticals, Inc., Filed with the Secretary of State of the State of Nevada
- 10.1 CNS Pharmaceuticals, Inc. 2020 Equity Plan (As Amended April 30, 2024)
- Download Excel data file
- View Excel data file
CNSP similar filings
- 5 Jun 24 CNS Pharmaceuticals Announces Reverse Stock Split
- 16 May 24 Company committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure
- 7 May 24 Other Events
- 3 May 24 Departure of Directors or Certain Officers
- 12 Apr 24 Regulation FD Disclosure
- 1 Apr 24 Berubicin study enrollment completed; Topline data expected in first half of 2025
- 27 Feb 24 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
Filing view
External links